Healthcare Mobility Solutions Market Is Expected To Grow At A CAGR Of 24.8% Over The Forecast Period 2014-2025

Global Healthcare Mobility Solutions Market is expected to reach USD 227.1 billion by 2025, according to a new study by Grand View Research, Inc. The market is driven by increasing demand for digitalization of healthcare. Rising health-related expenditure is the biggest issue many countries are facing nowadays. Hospitals are struggling to provide quality care and cost-effective services to patients. Moreover, political instability, lack of proactive initiatives, and economic stress are the factors questioning the R&D funding in developing nations.

Despite sufficient funding and insurance programs, there has been a constant increase in health expenditure in the U.S., affecting services offered by providers. To overcome this, healthcare mobility services are the best solutions, which is anticipated to propel the demand for these devices.

Full Research Report on Global Healthcare Mobility Solutions Market Analysis:
http://www.grandviewresearch.com/industry-analysis/healthcare-mobility-solutions-market

Further Key Findings From the Study Suggest:

• Enterprise mobility platforms are anticipated to show upward shift in the forecast period owing to the growing demand from hospitals and other caregivers, to manage and optimize operational efficiency
• mHealth application segment is expected to exhibit fastest growth rate over the forecast period. This can be attributed toward the growing adoption of mHealth apps by patients and care providers for remotely accessing patient health information
• Healthcare mobility solutions found wide applications in workforce management, to improve the operational capabilities of the employees and increase productivity
• Patient care management practices are anticipated to show lucrative CAGR over the forecast period due to rising patient concerns and demand for continuous monitoring
• Patients are anticipated to use the healthcare mobility solutions on a large scale in coming years, owing to rising awareness levels and penetration of mHealth apps
• Asia Pacific is expected to grow at an exponential CAGR as a consequence of high unmet needs and rapidly evolving pharma industry along with the growing awareness levels
• The key participants are involved in rigorous strategic activities, such as collaborative agreements & acquisitions, to gain competitive advantage in the market
• For instance, In April 2016, McKesson Acquired Biologics, Inc.a North Carolina-based biologics company that offers oncology pharmacy services to patients & providers and solutions to manufacturers & payers

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Healthcare Mobility Solutions Market on the basis of product & services, application, end-use and region:

Healthcare Mobility Solutions Product & Service Outlook (Revenue, USD Billion, 2014 - 2025)

• Mobile Devices
• Mobile Applications
• Enterprise Mobility Platforms

Healthcare Mobility Solutions Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Enterprise Solutions
• mHealth Applications

Healthcare Mobility Solutions End-Use Outlook (Revenue, USD Billion, 2014 - 2025)

• Payers
• Providers
• Patients

Healthcare Mobility Solutions Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Blog On this Report By Grand View Research: http://www.grandviewresearch.com/blog/healthcare-mobility-solutions-market-size        

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Healthcare IT Market Analysis By Application And Segment Forecast Up to 2020

Global Healthcare IT Market is anticipated to reach USD 104.5 billion by 2020, according to a new report by Grand View Research, Inc. Increasing demand for enhanced healthcare facilities and introduction of technologically advanced systems are expected to boost industry growth.

Increasing geriatric population prone to chronic diseases resulting into high patient base is triggering the demand for sophisticated healthcare facilities. Furthermore, increasing number of patients requiring home healthcare acts as an effective growth driver for this market.

Full Research Report on Global Healthcare IT Market Analysis:
http://www.grandviewresearch.com/industry-analysis/healthcare-it-market

According to a report published by the U.S. Centers for Disease Control and Prevention (CDC) in 2011, the number of patients needing home healthcare was nearly 4.7 million in the U.S. and is on a constant rise, which is further expected to fuel the healthcare IT market demand.

Advent of technologically advanced software, such as interoperable system and cloud computing, is expected to attract more investors focus on developing integrated healthcare system to curb problems associated with conventional procedures of record keeping. For example, the uses of e-healthcare record system to maintain patient database help to provide instant information about patients’ health in case of emergency.

Telecommunication and telehealth accounted for over 40.0% of the market share owing to the high usage rates in 2013. Introduction of technological advancements such as Teleimmersive Environment for Everybody (TEEVE) and Session Initiation Protocol (SIP) are the factors promoting this segment’s growth.

Electronic Health Records (EHR) is expected to register an upward shift to reach up to USD 26.72 billion in 2020. Growth is primarily driven by the rising demand for integrated information system in the field of healthcare IT. Faster accessibility and low maintenance cost are the two most significant factors contributing towards the rising demand of these EHR systems.

In 2013, North America market was valued at around USD 20.0 billion owing to the factors such as favorable government initiatives pertaining to the introduction of technologically advanced healthcare IT facilities, sophisticated healthcare infrastructure, and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region.

On the other hand, Asia Pacific healthcare IT market is expected to reach at over USD 19.6 billion by registering lucrative growth rate in 2020. Growth is attributed to the rising healthcare expenditure, larger untapped opportunities, and growing disposable income level.

Prominent players operating in this industry include Athenahealth Inc., GE Healthcare, Agfa Healthcare, Philips Healthcare, E-MDS Inc., Carestream Health McKesson Corporation, Carestream Health eClinicalworks, and Hewlett-Packard.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Global Healthcare IT Market on the basis of application and region:

Healthcare IT Application Outlook (Market Revenue in USD Million, 2012 - 2020)
            • Electronic Health Records
            • Computerized Provider Order Entry Systems
            • Electronic Prescribing Systems
            • PACS
            • Lab Information Systems
            • Clinical Information Systems
            • Telemedicine and Telehealth
            • Others

Healthcare IT Regional Outlook (Market Revenue in USD Million, 2012 - 2020)
            • North America
            • Europe
            • Asia Pacific
            • Rest of the World

View Press Release Of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-healthcare-it-market       

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Healthcare Cyber Security Market Analysis By End-Use, Type Of Threat, Type Of Solution And Segment Forecast Up To 2022

Global Healthcare Cyber Security Market size is expected to reach nearly USD 10,848.87million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to the growth of the market include the increasing incidences of cyber attacks for misuse of electronic patient health records (E-PHR), social security records, IP theft, and others. 

Cyber attacks are constantly increasing across the globe. On previous encounters it was witnessed that cyber attacks were focused on stealing, financial information, billing information, and bank account numbers using stolen devices with un-encrypted data, phishing and spam mails. Technological advancements have led to advanced cyber warfare using SQL injections, advanced persistent threats (APT), zero day attacks, and advanced malware. 

Lack of adequate IT spending by healthcare organizations and lack of awareness about cyber crime have exposed the vulnerabilities of healthcare organizations. The overall impact of cyber attacks on the hospitals and healthcare systems is estimated to be nearly six billion per year. 

Furthermore, these organizations face internal threats due to factors such as the use of cloud services, unsecure networks, employee negligence, bring your own device (BYOD), lack of internal identification and security systems, stolen devices with un-encrypted files. 

Healthcare cyber security market is segmented by, type of threat into malware, ddos, advanced persistent threat (apt), spyware, lost and stolen devices, others. In 2013, Boston Scientific, St.Jude Medical and, Medtronic witnessed cyber attacks and hacking. In 2015, Anthem, which is the second largest health insurance provider in the U.S., witnessed a massive cyber attack leading to loss of 80 million customer records. 

Security information and event management (SIEM),risk and compliance management, DDoS mitigation, antivirus, antimalware, identity and access management, intrusion detection system (IDS)/intrusion prevention system (IPS) and others are the solutions included in the scope of the study. These solutions can be used individually or can be used as a suite of products providing layer wise security. 

Market dynamics in this sector are dependent on the type of threat, effectiveness, and frequency of attack, ability to detect and destroy. New types of threats are detected each day, hence, the solutions need to be upgraded constantly to provide adequate firewall security and prevent data breach. 

Full Research Report on Global Healthcare Cyber Security Market Analysis:
http://www.grandviewresearch.com/industry-analysis/healthcare-cyber-security-market

Further key findings from the study suggest:

• In 2014, North America held the largest market share of more than 41% owing to the presence of sophisticated healthcare infrastructure, and increasing collaboration between pharmaceutical, medical device industries, with regulatory authorities. This can be illustrated using the U.S FDA guidance document on networked medical devices.
• Furthermore, the U.S. is a prime target for cyber crimes due to, the presence of large fortune 500 healthcare organizations, full scale implementation of digital patient records, and use of extensive social security ids for various transactions.
• Asia Pacific is identified as one of the most lucrative regional market, growing at a CAGR of over 8.5% during the forecast period. Rapidly improving healthcare infrastructure and high level economic growth in developing countries such as China, India, and South Korea is expected to boost usage rates over the forecast period.
• Increasing number of internet users in China and India is expected to create a huge user base vulnerable to cyber attacks. According to data published by the Internet and Mobile Association of India (IAMAI), the internet user base in India is expected to reach nearly 402 million by December 2015
• Key players operating in the healthcare cyber security market include, Cisco, IBM, MacAfee, Paulo Alto Networks, Symantec, Trend Micro Lockheed Martin, FireEye, Northrop Grumma, Kaspersky etc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Healthcare Cyber Security market on the basis of end-use, type of threat, type of solution, and region:

Healthcare Cyber Security End-Use Outlook (Revenue, USD Million, 2014 - 2022)

• Pharmaceuticals & Chemicals
• Medical Devices
• Health Insurance
• Hospitals
• Others

Healthcare Cyber Security Type of Threat Outlook (Revenue, USD Million, 2014 - 2022)

• Pharmaceuticals & Chemicals
• Malware
• DDoS
• Advanced Persistent Threats (APT)
• Spyware
• Lost or Stolen Devices
• Others

Healthcare Cyber Security Type of Solution Outlook (Market Revenue in USD Million, 2012 - 2022)

• Identity and Access Management
• Risk and Compliance Management
• Antivirus and Antimalware
• DDoS Mitigation
• Security Information and Event Management (SIEM)
• Intrusion Detection System (IDS)/Intrusion Prevention System (IPS)
• Others

Healthcare Cyber Security Regional Outlook (Revenue, USD Million, 2014 - 2022)

• North America
• U.S.
• Canada

• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-healthcare-cyber-security-market      

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Healthcare Analytics Market Analysis By Type, Delivery Mode, Component, Application, End-Use And Segment Forecast Up To 2024

Global Healthcare Analytics (HA) Market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

Full Research Report on Global Healthcare Analytics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the study suggest:

• Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.

• The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.

• The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.

• On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.

• The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.

• The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.

• The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.

• North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.

• The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.

• Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

• For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Healthcare Analytics Market on the basis of products, end-use, and region:

Global Healthcare Analytics Market by Type, 2013 - 2024 (USD Million)

• Descriptive Analytics
• Predictive Analytics
• Prescriptive Analytics

Global Healthcare Analytics Market by Component, 2013 - 2024 (USD Million)

• Software
• Hardware
• Services

Global Healthcare Analytics Market, by Delivery Mode, 2013 - 2024 (USD Million)

• On-premise
• Web-based
• Cloud-based

Global Healthcare Analytics Market, by Application, 2013 - 2024 (USD Million)

• Clinical
• Financial
• Operational and Administrative

Global Healthcare Analytics Market, by End-use, 2013 - 2024 (USD Million)

• Healthcare Payers
• Healthcare Providers
• Others

Healthcare Analytics Devices Market, By Region, 2013 - 2024 (USD Million)

• North America
• U.S.
• Canada
• Europe
• UK
• Spain
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-healthcare-analytics-market     

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Regenerative Medicine Market Analysis By Product, Tools, Banks, Therapeutic Category And Segment Forecasts 2014 - 2025

Global Regenerative Medicine Market size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Biologics, individually or in combination with cells or devices, are explored to support regenerate the biological functions of cells, tissues, or organs. A number of combinatorial therapies to support chemotherapy and other cancer treatments by prevention as well as treatment for cancer relapse are in development phases.

In addition, rising prevalence of complicated degenerative disorders such as age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the aging population resulted in high investments in R&D to develop therapeutic solutions.

Regenerative medicine grabs the attention of the healthcare industry owing to its promising applications along with significant advances in supportive fields including tissue engineering, stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D printing over scaffold with stem cells to restore structure as well as functional characteristics of biological cells, tissues, and organs.

Full Research report on Global Regenerative Medicine Market Analysis: http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market

Further key findings from the report suggest:

• The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner
• Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption
• Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.
• Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Regenerative Medicine Market on the basis of product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2014 - 2025)

• Therapeutics & Devices
• Primary Cell-bases therapeutics 

§  Dermatology

§  Musculoskeletal

§  Surgical

§  Dental

§  Others

·         Stem Cell & Progenitor Cell-based therapeutics

§  Autologous

§  Allogeneic

§  Others

·         Tools

·         Banks

·         Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatology
• Musculoskeletal
• Immunology & Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Middle East & Africa
• South Africa

View Blog On This Research Report By Grand View Research: http://www.grandviewresearch.com/blog/regenerative-medicine-market-size             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Epigenetics Market Is Expected To Grow At A CAGR Of 19.3% Over The Forecast Period 2012-2022

Global Epigenetics Market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period. 

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs. 

Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer. 

Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene. 

Full Research Report on Global Epigenetics Market Analysis: 
http://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the report suggest:

• Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
• DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.
• Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.
• Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.
• North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.
• The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs
• Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.
• Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Epigenetics Market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

• Reagents
• Kits
• Instruments
• Enzymes
• Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large noncoding RNA
• MicroRNA Modification
• Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

• Oncology
• Solid Tumors
• Liquid Tumors
• Non Oncology
• Inflammatory Diseases
• Metabolic Diseases
• Infectious Diseases
• Cardiovascular Diseases

Epigenetics Market  Regional Outlook(Revenue, USD Million, 2015 – 2022)

• North America

§  U.S.

§  Canada

·         Europe

§  UK

§  Germany

·         Asia Pacific

§  Japan

§  China

§  India

·         Latin America

§  Brazil

§  Mexico

·         Middle East and Africa (MEA)

§  South Africa

View Press Release of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-epigenetics-market       

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Proton Therapy Systems Market Qualitative Analysis By Industry Overview, Trends, Market Drivers And Restraints 2014-2025

Global Proton Therapy Systems Market is expected to reach USD 2.88 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Full Research Report on Global Proton Therapy Systems Market Analysis:  http://www.grandviewresearch.com/industry-analysis/proton-therapy-systems-market

Further Key Findings From the Report Suggest:

• The equipment segment held majority of the revenue share in 2016 due to rise in the number of contracts for establishment of proton therapy centers
• North America dominated the global market owing to strong reimbursement framework and high adoption of this therapy

• Some of the key players areMevion Medical Systems; IBA, Optivus Proton Therapy, Inc.; Advanced Oncotherapy plc; Varian Medical Systems, Inc.; Hitachi, Ltd.; and Mitsubishi Corporation.
• The single-room systems segment is expected to command the largest share of the market in 2025.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Proton Therapy Systems Market on the basis of product, type, and region:

Proton Therapy Systems Product Outlook (Revenue, USD Million, 2014 - 2025)

• Equipment
• Services

Proton Therapy Systems Type Outlook (Revenue, USD Million, 2014 - 2025)

• Single-Room Systems
• Multi-Room Systems

Proton Therapy Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release of this Report By Grand View Research: 

http://www.grandviewresearch.com/press-release/global-proton-therapy-systems-market      

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com